EMPAGLIFLOZIN

EMPAGLIFLOZIN was reported 69480 times

These side effects are most commonly reported by patients taking EMPAGLIFLOZIN:

# Side effect Count
0 DIABETIC KETOACIDOSIS 3903
1 NAUSEA 3728
2 DIARRHOEA 3406
3 BLOOD GLUCOSE INCREASED 3255
4 FATIGUE 3031
5 WEIGHT DECREASED 3000
6 OFF LABEL USE 2916
7 VOMITING 2802
8 DIZZINESS 2775
9 DYSPNOEA 2526
10 DRUG INEFFECTIVE 2501
11 FUNGAL INFECTION 2167
12 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2079
13 HEADACHE 2047
14 URINARY TRACT INFECTION 2035
15 ACUTE KIDNEY INJURY 1898
16 ASTHENIA 1701
17 DEHYDRATION 1624
18 DEATH 1600
19 DECREASED APPETITE 1548
20 KETOACIDOSIS 1524
21 MALAISE 1507
22 HYPOTENSION 1496
23 FALL 1469
24 PAIN 1468
25 COUGH 1437
26 PRURITUS 1393
27 RASH 1313
28 CONSTIPATION 1276
29 ARTHRALGIA 1272
30 GLYCOSYLATED HAEMOGLOBIN INCREASED 1262
31 PRODUCT DOSE OMISSION ISSUE 1252
32 ABDOMINAL PAIN 1201
33 COVID-19 1194
34 PNEUMONIA 1157
35 PAIN IN EXTREMITY 1128
36 FOURNIER^S GANGRENE 1115
37 POLLAKIURIA 1098
38 CARDIAC FAILURE 1080
39 ABDOMINAL PAIN UPPER 1046
40 ABDOMINAL DISCOMFORT 963
41 CEREBROVASCULAR ACCIDENT 953
42 PYREXIA 921
43 WEIGHT INCREASED 911
44 CONDITION AGGRAVATED 894
45 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 876
46 BACK PAIN 862
47 MYOCARDIAL INFARCTION 856
48 SEPSIS 849
49 PERIPHERAL SWELLING 818
50 FEELING ABNORMAL 768
51 INJECTION SITE PAIN 767
52 ATRIAL FIBRILLATION 753
53 HYPERTENSION 751
54 METABOLIC ACIDOSIS 748
55 LACTIC ACIDOSIS 736
56 ILLNESS 722
57 SOMNOLENCE 720
58 IMPAIRED GASTRIC EMPTYING 701
59 INCORRECT DOSE ADMINISTERED 685
60 BLOOD PRESSURE INCREASED 683
61 CHEST PAIN 683
62 BLOOD GLUCOSE DECREASED 674
63 HYPOGLYCAEMIA 673
64 RENAL IMPAIRMENT 667
65 PRODUCT USE IN UNAPPROVED INDICATION 661
66 DEPRESSION 657
67 INSOMNIA 636
68 CONFUSIONAL STATE 634
69 BLOOD GLUCOSE ABNORMAL 621
70 GAIT DISTURBANCE 608
71 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 593
72 PANCREATITIS 591
73 DIABETES MELLITUS 580
74 NASOPHARYNGITIS 580
75 INTENTIONAL PRODUCT USE ISSUE 579
76 ANXIETY 575
77 MUSCLE SPASMS 569
78 DYSPEPSIA 565
79 RENAL FAILURE 549
80 MYALGIA 547
81 PALPITATIONS 530
82 VISUAL IMPAIRMENT 530
83 ANAEMIA 523
84 HYPERGLYCAEMIA 519
85 DRUG INTERACTION 516
86 ABDOMINAL DISTENSION 510
87 CARDIAC DISORDER 508
88 OEDEMA PERIPHERAL 495
89 BLOOD CREATININE INCREASED 491
90 LOSS OF CONSCIOUSNESS 480
91 MEMORY IMPAIRMENT 473
92 GENERAL PHYSICAL HEALTH DETERIORATION 471
93 BLOOD PRESSURE DECREASED 468
94 HYPERHIDROSIS 468
95 VISION BLURRED 464
96 TREMOR 455
97 INFECTION 449
98 HYPERKALAEMIA 439
99 CARDIAC FAILURE CONGESTIVE 432
100 DYSURIA 423
101 DRY MOUTH 422
102 SYNCOPE 419
103 MUSCULAR WEAKNESS 418
104 HYPOAESTHESIA 414
105 STRESS 408
106 PRODUCT USE ISSUE 405
107 ERYTHEMA 401
108 HEART RATE INCREASED 400
109 ALOPECIA 393
110 THIRST 393
111 GLOMERULAR FILTRATION RATE DECREASED 391
112 ARTHRITIS 390
113 CHEST DISCOMFORT 390
114 CHRONIC KIDNEY DISEASE 373
115 INFLUENZA 373
116 DIABETES MELLITUS INADEQUATE CONTROL 367
117 HYPERSENSITIVITY 362
118 FLUID RETENTION 359
119 URTICARIA 355
120 RENAL DISORDER 349
121 NEUROPATHY PERIPHERAL 346
122 EPISTAXIS 343
123 OXYGEN SATURATION DECREASED 343
124 FLATULENCE 342
125 TACHYCARDIA 341
126 GASTROINTESTINAL DISORDER 339
127 CHILLS 338
128 VERTIGO 336
129 JOINT SWELLING 334
130 DRUG HYPERSENSITIVITY 332
131 HYPOACUSIS 332
132 OROPHARYNGEAL PAIN 327
133 HAEMATOCHEZIA 324
134 GASTROOESOPHAGEAL REFLUX DISEASE 323
135 HOT FLUSH 323
136 PSORIASIS 323
137 DRY SKIN 321
138 DYSPNOEA EXERTIONAL 317
139 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 317
140 THERAPY INTERRUPTED 317
141 ASTHMA 314
142 PULMONARY EMBOLISM 311
143 INJECTION SITE HAEMORRHAGE 302
144 RHINORRHOEA 300
145 DYSPHAGIA 299
146 SWELLING 293
147 HOSPITALISATION 292
148 MIGRAINE 287
149 CATARACT 286
150 DYSGEUSIA 281
151 PARAESTHESIA 275
152 CARDIAC ARREST 274
153 ACCIDENTAL OVERDOSE 273
154 UROSEPSIS 272
155 HAEMATURIA 269
156 MEDICATION ERROR 268
157 CONTUSION 265
158 PRODUCTIVE COUGH 263
159 BALANCE DISORDER 262
160 CELLULITIS 262
161 SEPTIC SHOCK 259
162 NASAL CONGESTION 257
163 SINUSITIS 257
164 DRUG INTOLERANCE 254
165 NECROTISING FASCIITIS 254
166 SURGERY 254
167 OEDEMA 253
168 HYPOPHAGIA 252
169 INJECTION SITE BRUISING 248
170 ADVERSE DRUG REACTION 246
171 LETHARGY 246
172 ACUTE MYOCARDIAL INFARCTION 243
173 HAEMOGLOBIN DECREASED 243
174 INTENTIONAL PRODUCT MISUSE 243
175 NEPHROLITHIASIS 242
176 URINARY INCONTINENCE 240
177 TOXICITY TO VARIOUS AGENTS 239
178 ECZEMA 238
179 HYPOKALAEMIA 234
180 EYE PAIN 232
181 DEEP VEIN THROMBOSIS 231
182 PANCREATITIS ACUTE 228
183 PLATELET COUNT DECREASED 228
184 HYPOVOLAEMIA 227
185 FREQUENT BOWEL MOVEMENTS 226
186 HYPONATRAEMIA 226
187 EXTRA DOSE ADMINISTERED 223
188 RECTAL HAEMORRHAGE 223
189 SWOLLEN TONGUE 223
190 ABNORMAL LOSS OF WEIGHT 221
191 CYSTITIS 220
192 ACIDOSIS 216
193 HEPATIC ENZYME INCREASED 216
194 THROMBOSIS 216
195 ARRHYTHMIA 213
196 COLITIS ULCERATIVE 213
197 POLYURIA 213
198 PULMONARY OEDEMA 211
199 VULVOVAGINAL PRURITUS 211
200 BLOOD GLUCOSE FLUCTUATION 210
201 SLEEP DISORDER 209
202 EJECTION FRACTION DECREASED 208
203 BRONCHITIS 207
204 SKIN EXFOLIATION 207
205 TINNITUS 206
206 SKIN ULCER 205
207 PLEURAL EFFUSION 204
208 THERAPY CESSATION 203
209 WHEEZING 203
210 CHOLELITHIASIS 202
211 NEOPLASM MALIGNANT 201
212 C-REACTIVE PROTEIN INCREASED 200
213 DYSPHONIA 200
214 INTESTINAL OBSTRUCTION 200
215 LIMB INJURY 198
216 MUSCULOSKELETAL STIFFNESS 197
217 TYPE 2 DIABETES MELLITUS 197
218 ANGINA PECTORIS 196
219 DEVICE ISSUE 196
220 THERAPEUTIC RESPONSE UNEXPECTED 195
221 THROAT IRRITATION 195
222 CANDIDA INFECTION 194
223 CORONARY ARTERY DISEASE 194
224 BLOOD CHOLESTEROL INCREASED 193
225 BRONCHIECTASIS 193
226 SWELLING FACE 193
227 THROMBOCYTOPENIA 192
228 ERUCTATION 191
229 INJECTION SITE ERYTHEMA 191
230 HAEMORRHAGE 190
231 MOBILITY DECREASED 190
232 OSTEOARTHRITIS 189
233 BLOOD POTASSIUM INCREASED 187
234 GASTROINTESTINAL HYPOMOTILITY 185
235 OVERDOSE 185
236 FLUSHING 184
237 RESPIRATORY FAILURE 183
238 HALLUCINATION 182
239 BRADYCARDIA 181
240 CEREBRAL INFARCTION 181
241 SEIZURE 181
242 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 180
243 THERAPY NON-RESPONDER 180
244 BURNING SENSATION 179
245 BLOOD POTASSIUM DECREASED 178
246 RHABDOMYOLYSIS 178
247 IMPAIRED QUALITY OF LIFE 177
248 VULVOVAGINAL MYCOTIC INFECTION 177
249 DISCOMFORT 176
250 TOE AMPUTATION 176
251 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 174
252 TUBULOINTERSTITIAL NEPHRITIS 174
253 URINARY RETENTION 174
254 PRURITUS GENITAL 170
255 RHEUMATOID ARTHRITIS 169
256 HEART RATE DECREASED 168
257 INJECTION SITE PRURITUS 168
258 URINE KETONE BODY PRESENT 168
259 INFLAMMATION 167
260 AMNESIA 166
261 NECK PAIN 166
262 INJECTION SITE MASS 165
263 NIGHTMARE 165
264 ALTERED STATE OF CONSCIOUSNESS 164
265 SUICIDAL IDEATION 164
266 LUNG DISORDER 161
267 WHITE BLOOD CELL COUNT DECREASED 160
268 INFLUENZA LIKE ILLNESS 158
269 UNDERDOSE 158
270 LOCALISED INFECTION 156
271 BLISTER 155
272 BLOOD UREA INCREASED 155
273 DEVICE LEAKAGE 155
274 PRODUCT PRESCRIBING ERROR 155
275 TRANSIENT ISCHAEMIC ATTACK 155
276 DISTURBANCE IN ATTENTION 154
277 BLOOD KETONE BODY INCREASED 153
278 SYSTEMIC LUPUS ERYTHEMATOSUS 153
279 TREATMENT NONCOMPLIANCE 153
280 CARDIAC MURMUR 152
281 BLINDNESS 151
282 BLOOD TRIGLYCERIDES INCREASED 151
283 DEMENTIA 151
284 DISEASE PROGRESSION 151
285 DIZZINESS POSTURAL 151
286 GAIT INABILITY 151
287 GASTROINTESTINAL HAEMORRHAGE 151
288 BLOOD PRESSURE SYSTOLIC INCREASED 150
289 SEASONAL ALLERGY 149
290 ANGIOEDEMA 148
291 CARDIAC OPERATION 148
292 EYE IRRITATION 148
293 GINGIVAL PAIN 148
294 HYPOXIA 148
295 PRESYNCOPE 148
296 DEVICE MALFUNCTION 146
297 IMPAIRED WORK ABILITY 146
298 KETOSIS 146
299 MICTURITION URGENCY 146
300 CARDIAC FAILURE CHRONIC 145
301 ALANINE AMINOTRANSFERASE INCREASED 144
302 TASTE DISORDER 144
303 FEELING HOT 143
304 PAROSMIA 143
305 UPPER RESPIRATORY TRACT INFECTION 143
306 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 142
307 BLOOD URINE PRESENT 141
308 GLUCOSE URINE PRESENT 141
309 NEUTROPENIA 141
310 ANAPHYLACTIC REACTION 140
311 RHINITIS 140
312 DELIRIUM 139
313 HAEMOGLOBIN INCREASED 139
314 EYE SWELLING 137
315 INJECTION SITE SWELLING 137
316 INFUSION SITE PAIN 135
317 SKIN DISORDER 135
318 GASTROENTERITIS 133
319 NO ADVERSE EVENT 133
320 PYELONEPHRITIS 133
321 DISORIENTATION 132
322 GANGRENE 132
323 HEPATIC STEATOSIS 132
324 PRODUCT STORAGE ERROR 132
325 RASH PRURITIC 132
326 GLYCOSYLATED HAEMOGLOBIN DECREASED 131
327 LOWER RESPIRATORY TRACT INFECTION 131
328 VENTRICULAR TACHYCARDIA 131
329 BURNS SECOND DEGREE 130
330 HERPES ZOSTER 130
331 HYPOPNOEA 130
332 ROAD TRAFFIC ACCIDENT 130
333 DEPRESSED MOOD 129
334 DEPRESSED LEVEL OF CONSCIOUSNESS 128
335 NERVOUSNESS 128
336 CONTRAINDICATED PRODUCT ADMINISTERED 127
337 MALIGNANT NEOPLASM PROGRESSION 127
338 WHITE BLOOD CELL COUNT INCREASED 127
339 HEAD INJURY 126
340 NOCTURIA 126
341 ILL-DEFINED DISORDER 125
342 KIDNEY INFECTION 125
343 SPEECH DISORDER 125
344 BLOOD PRESSURE ABNORMAL 124
345 HYPERTHYROIDISM 124
346 SKIN DISCOLOURATION 124
347 STEROID DEPENDENCE 124
348 CATARRH 123
349 PRODUCT DOSE OMISSION IN ERROR 123
350 PULMONARY HYPERTENSION 122
351 WOUND 122
352 INTENTIONAL DOSE OMISSION 121
353 KETONURIA 121
354 MITRAL VALVE INCOMPETENCE 121
355 PROTEINURIA 121
356 DRY EYE 120
357 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 120
358 COMA 119
359 SHOCK 119
360 LEUKOCYTOSIS 118
361 PANCREATIC CARCINOMA 118
362 BLOOD PRESSURE FLUCTUATION 117
363 LIMB DISCOMFORT 117
364 PRODUCT QUALITY ISSUE 117
365 SLEEP APNOEA SYNDROME 117
366 ACUTE RESPIRATORY FAILURE 115
367 PRODUCT DOSE OMISSION 115
368 HYPERVOLAEMIA 114
369 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114
370 BONE PAIN 113
371 OCULAR HYPERAEMIA 113
372 OSTEOMYELITIS 113
373 BREAST CANCER 112
374 BALANOPOSTHITIS 111
375 ELECTROLYTE IMBALANCE 111
376 HUNGER 111
377 ILEUS 111
378 PSORIATIC ARTHROPATHY 111
379 CHOLECYSTITIS 110
380 FEEDING DISORDER 110
381 HEPATIC CIRRHOSIS 110
382 BLOOD SODIUM DECREASED 109
383 UNEVALUABLE EVENT 109
384 AGEUSIA 108
385 CARDIAC FAILURE ACUTE 108
386 ADVERSE EVENT 107
387 ARTHROPATHY 106
388 GENITAL INFECTION FUNGAL 106
389 HIP FRACTURE 106
390 RASH MACULAR 106
391 DRUG-INDUCED LIVER INJURY 105
392 INTERSTITIAL LUNG DISEASE 105
393 LIVER DISORDER 105
394 TROPONIN INCREASED 104
395 DISEASE RECURRENCE 103
396 HEART RATE IRREGULAR 103
397 ORTHOSTATIC HYPOTENSION 103
398 ACCIDENTAL UNDERDOSE 102
399 EYE PRURITUS 102
400 STOMATITIS 102
401 URINE ODOUR ABNORMAL 102
402 POLYDIPSIA 101
403 BRAIN FOG 100
404 LACRIMATION INCREASED 100
405 PNEUMONIA ASPIRATION 100
406 POST PROCEDURAL COMPLICATION 100
407 BLADDER CANCER 99
408 DIVERTICULITIS 99
409 INCREASED APPETITE 99
410 JOINT INJURY 99
411 LIP SWELLING 99
412 PAIN IN JAW 99
413 MELAENA 98
414 CEREBRAL HAEMORRHAGE 97
415 COGNITIVE DISORDER 97
416 NIGHT SWEATS 97
417 POLYCYTHAEMIA 97
418 RENAL PAIN 97
419 TACHYPNOEA 97
420 FEELING COLD 96
421 GOUT 96
422 RETCHING 96
423 ASPARTATE AMINOTRANSFERASE INCREASED 95
424 CORONARY ARTERY OCCLUSION 95
425 EMOTIONAL DISTRESS 95
426 NEEDLE ISSUE 95
427 FEBRILE NEUTROPENIA 94
428 MALNUTRITION 94
429 ALCOHOL POISONING 93
430 BLOOD IRON DECREASED 93
431 CARDIOMYOPATHY 93
432 EATING DISORDER 93
433 HYPERSOMNIA 93
434 PERICARDIAL EFFUSION 93
435 RED BLOOD CELL COUNT DECREASED 93
436 STAPHYLOCOCCAL INFECTION 93
437 ACCIDENTAL EXPOSURE TO PRODUCT 92
438 CHROMATURIA 92
439 IMPAIRED HEALING 92
440 WEIGHT FLUCTUATION 92
441 ACNE 91
442 AGITATION 91
443 ERECTILE DYSFUNCTION 91
444 FULL BLOOD COUNT ABNORMAL 91
445 INCORRECT DOSE ADMINISTERED BY DEVICE 91
446 ADRENAL INSUFFICIENCY 90
447 EYE DISORDER 90
448 GASTRITIS 90
449 HYPERNATRAEMIA 89
450 INTENTIONAL OVERDOSE 89
451 LEFT VENTRICULAR DYSFUNCTION 89
452 PALLOR 89
453 POOR QUALITY SLEEP 89
454 RASH ERYTHEMATOUS 89
455 URINE ABNORMALITY 89
456 HAEMATOCRIT INCREASED 87
457 INCONTINENCE 87
458 MUSCLE ATROPHY 87
459 PEMPHIGOID 87
460 VIRAL INFECTION 87
461 COLD SWEAT 86
462 GASTROENTERITIS VIRAL 86
463 RIB FRACTURE 86
464 TREATMENT FAILURE 86
465 CARDIOGENIC SHOCK 85
466 CROHN^S DISEASE 85
467 DIABETIC FOOT 85
468 COLITIS 84
469 ABDOMINAL PAIN LOWER 83
470 HYPOTHYROIDISM 83
471 THERAPEUTIC RESPONSE SHORTENED 83
472 HAEMORRHOIDS 82
473 PRODUCT ADMINISTRATION ERROR 82
474 SINUS DISORDER 82
475 THERAPEUTIC RESPONSE DECREASED 82
476 ANAL INCONTINENCE 81
477 DYSSTASIA 81
478 IRRITABILITY 81
479 SCIATICA 81
480 BACTERIAL INFECTION 80
481 DIABETIC METABOLIC DECOMPENSATION 80
482 FAECES DISCOLOURED 80
483 INFUSION RELATED REACTION 80
484 PRESCRIBED UNDERDOSE 80
485 PROSTATE CANCER 80
486 APHASIA 79
487 LEG AMPUTATION 79
488 NEURALGIA 79
489 OBESITY 79
490 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 79
491 RESPIRATORY TRACT INFECTION 79
492 DIABETIC NEUROPATHY 78
493 MENTAL DISORDER 78
494 PULMONARY CONGESTION 78
495 GLYCOSURIA 77
496 LABORATORY TEST ABNORMAL 77
497 SNEEZING 77
498 COVID-19 PNEUMONIA 76
499 HAEMATEMESIS 76
500 HEPATIC FUNCTION ABNORMAL 76
501 INFUSION SITE ERYTHEMA 76
502 ISCHAEMIC STROKE 76
503 KNEE ARTHROPLASTY 76
504 MOVEMENT DISORDER 76
505 MUSCULOSKELETAL PAIN 76
506 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 76
507 VENTRICULAR EXTRASYSTOLES 76
508 CARDIOVASCULAR DISORDER 75
509 DERMATITIS ATOPIC 75
510 PROCEDURAL PAIN 75
511 RENAL INJURY 75
512 VAGINAL HAEMORRHAGE 75
513 LIPASE INCREASED 74
514 DIPLOPIA 73
515 GASTRIC DISORDER 73
516 PSYCHOTIC DISORDER 73
517 THERAPEUTIC PRODUCT EFFECT DECREASED 73
518 BLOOD CREATINE PHOSPHOKINASE INCREASED 72
519 FEELING JITTERY 72
520 PERIPHERAL COLDNESS 72
521 SKIN LESION 72
522 UPPER LIMB FRACTURE 72
523 AGGRESSION 71
524 BLOOD PRESSURE DIASTOLIC DECREASED 71
525 COLON CANCER 71
526 DEVICE DIFFICULT TO USE 71
527 HAEMATOMA 71
528 MENTAL STATUS CHANGES 71
529 MUSCULOSKELETAL DISCOMFORT 71
530 PANIC ATTACK 71
531 SPINAL OPERATION 71
532 DRUG DOSE OMISSION 70
533 DRUG DOSE OMISSION BY DEVICE 70
534 FIBROMYALGIA 70
535 FLANK PAIN 70
536 LIVER FUNCTION TEST INCREASED 70
537 LUNG NEOPLASM MALIGNANT 70
538 RESPIRATORY TRACT CONGESTION 70
539 RESTLESSNESS 70
540 DIABETIC RETINOPATHY 69
541 DYSARTHRIA 69
542 PRODUCT PRESCRIBING ISSUE 69
543 RESPIRATORY DISORDER 69
544 SKIN BURNING SENSATION 69
545 VENTRICULAR FIBRILLATION 69
546 CYST 68
547 GLOMERULAR FILTRATION RATE ABNORMAL 68
548 PRODUCT DISPENSING ERROR 68
549 CIRCULATORY COLLAPSE 67
550 HAEMOPTYSIS 67
551 ORAL CANDIDIASIS 67
552 PANCYTOPENIA 67
553 THROAT TIGHTNESS 67
554 ABSCESS 66
555 BACK DISORDER 66
556 ORAL PAIN 66
557 PRODUCT MONITORING ERROR 66
558 PRODUCT SUBSTITUTION ISSUE 66
559 PROSTATITIS 66
560 TOOTHACHE 66
561 URINE OUTPUT INCREASED 66
562 BLOOD LACTIC ACID INCREASED 65
563 GENERALISED OEDEMA 65
564 HAEMATOCRIT DECREASED 65
565 INTERVERTEBRAL DISC PROTRUSION 65
566 IRON DEFICIENCY ANAEMIA 65
567 OSTEOPOROSIS 65
568 CORONARY ARTERY BYPASS 64
569 GASTRIC ULCER 64
570 RENAL TUBULAR NECROSIS 64
571 ANION GAP INCREASED 63
572 GENITAL INFECTION 63
573 INSURANCE ISSUE 63
574 MOOD ALTERED 63
575 SKIN FISSURES 63
576 SMALL INTESTINAL OBSTRUCTION 63
577 VULVOVAGINAL DISCOMFORT 63
578 BLOOD ALKALINE PHOSPHATASE INCREASED 62
579 CARDIOMEGALY 62
580 DYSKINESIA 62
581 HYPOMAGNESAEMIA 62
582 LOWER LIMB FRACTURE 62
583 LYMPHADENOPATHY 62
584 SKIN IRRITATION 62
585 SKIN LACERATION 62
586 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 62
587 CARPAL TUNNEL SYNDROME 61
588 ELECTROCARDIOGRAM QT PROLONGED 61
589 PHIMOSIS 61
590 PRODUCT USE COMPLAINT 61
591 TENDONITIS 61
592 ANAL ABSCESS 60
593 DEAFNESS 60
594 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 60
595 GENITAL RASH 60
596 HERNIA 60
597 LIVER INJURY 60
598 MIDDLE INSOMNIA 60
599 OLIGURIA 60
600 UNRESPONSIVE TO STIMULI 60
601 BLOOD IMMUNOGLOBULIN E INCREASED 59
602 BACTERAEMIA 58
603 DEVICE DELIVERY SYSTEM ISSUE 58
604 DRUG ERUPTION 58
605 GLAUCOMA 58
606 GROIN PAIN 58
607 HYPERLIPIDAEMIA 58
608 MALIGNANT MEDIASTINAL NEOPLASM 58
609 MUSCLE TIGHTNESS 58
610 SYSTEMIC CANDIDA 58
611 BLOOD BILIRUBIN INCREASED 57
612 CARDIO-RESPIRATORY ARREST 57
613 COMPLETED SUICIDE 57
614 DECUBITUS ULCER 57
615 DIABETIC COMA 57
616 PNEUMONITIS 57
617 TRICUSPID VALVE INCOMPETENCE 57
618 VAGINAL INFECTION 57
619 BRASH SYNDROME 56
620 DRY THROAT 56
621 ESCHERICHIA INFECTION 56
622 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 56
623 HYPOKINESIA 56
624 JOINT STIFFNESS 56
625 SKIN HAEMORRHAGE 56
626 VULVOVAGINAL BURNING SENSATION 56
627 MYOCARDIAL ISCHAEMIA 55
628 OCULAR DISCOMFORT 55
629 ATRIOVENTRICULAR BLOCK 54
630 BLOOD PRESSURE SYSTOLIC DECREASED 54
631 BODY TEMPERATURE INCREASED 54
632 EAR INFECTION 54
633 HEPATIC FAILURE 54
634 MUSCULOSKELETAL CHEST PAIN 54
635 PANCREATITIS NECROTISING 54
636 ANURIA 53
637 ARTERIOSCLEROSIS 53
638 EXPIRED PRODUCT ADMINISTERED 53
639 PAIN OF SKIN 53
640 PULMONARY MASS 53
641 SPUTUM DISCOLOURED 53
642 THROAT CLEARING 53
643 BLOOD CREATINE INCREASED 52
644 BLOOD KETONE BODY 52
645 CHOLECYSTECTOMY 52
646 DECREASED ACTIVITY 52
647 DERMATITIS CONTACT 52
648 FOOT FRACTURE 52
649 HEPATITIS 52
650 HYPOCALCAEMIA 52
651 INJURY 52
652 JAUNDICE 52
653 JOINT EFFUSION 52
654 PRODUCT AVAILABILITY ISSUE 52
655 ARTERIAL OCCLUSIVE DISEASE 51
656 ASCITES 51
657 DISABILITY 51
658 DRUG EFFECT LESS THAN EXPECTED 51
659 FEMUR FRACTURE 51
660 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51
661 GASTROINTESTINAL PAIN 51
662 HYPERCALCAEMIA 51
663 INJECTION SITE REACTION 51
664 PLASMA CELL MYELOMA 51
665 PNEUMOTHORAX 51
666 PRODUCT ADMINISTRATION INTERRUPTED 51
667 ROTATOR CUFF SYNDROME 51
668 ULCER 51
669 APHONIA 50
670 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50
671 INJECTION SITE RASH 50
672 PROSTATIC SPECIFIC ANTIGEN INCREASED 50
673 PROTEIN URINE PRESENT 50
674 SPINAL PAIN 50
675 STAPHYLOCOCCAL BACTERAEMIA 50
676 TENDERNESS 50
677 BLINDNESS UNILATERAL 49
678 ENERGY INCREASED 49
679 HYDRONEPHROSIS 49
680 NEPHROPATHY 49
681 OROPHARYNGEAL DISCOMFORT 49
682 PARKINSON^S DISEASE 49
683 PRERENAL FAILURE 49
684 ABSCESS LIMB 48
685 BASAL CELL CARCINOMA 48
686 BLADDER DISORDER 48
687 BLOOD URIC ACID INCREASED 48
688 CARDIAC PACEMAKER INSERTION 48
689 CLOSTRIDIUM DIFFICILE INFECTION 48
690 INABILITY TO AFFORD MEDICATION 48
691 NEUTROPHIL COUNT DECREASED 48
692 RED BLOOD CELL COUNT INCREASED 48
693 RESTLESS LEGS SYNDROME 48
694 URINE KETONE BODY 48
695 AGRANULOCYTOSIS 47
696 ANKLE FRACTURE 47
697 ANXIETY DISORDER 47
698 CHOLESTASIS 47
699 INFUSION SITE SWELLING 47
700 PHOTOPHOBIA 47
701 RED CELL DISTRIBUTION WIDTH INCREASED 47
702 SARS-COV-2 TEST POSITIVE 47
703 SPINAL FRACTURE 47
704 SUBDURAL HAEMATOMA 47
705 VITAMIN D DEFICIENCY 47
706 DRUG LEVEL INCREASED 46
707 ELECTROCARDIOGRAM ABNORMAL 46
708 EYE INFECTION 46
709 FRACTURE 46
710 IRON DEFICIENCY 46
711 LEFT VENTRICULAR HYPERTROPHY 46
712 PULMONARY ARTERIAL HYPERTENSION 46
713 RESPIRATORY ARREST 46
714 SINUS CONGESTION 46
715 ABNORMAL DREAMS 45
716 BACK INJURY 45
717 CUTANEOUS VASCULITIS 45
718 FLUID INTAKE REDUCED 45
719 HICCUPS 45
720 HYPOVOLAEMIC SHOCK 45
721 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45
722 INJECTION SITE WARMTH 45
723 MYOPATHY 45
724 ORCHITIS 45
725 PERINEAL INFECTION 45
726 PLATELET COUNT INCREASED 45
727 SYNOVITIS 45
728 THERAPY CHANGE 45
729 VITAMIN B12 DECREASED 45
730 ANAPHYLACTIC SHOCK 44
731 ASPIRATION 44
732 ATRIAL FLUTTER 44
733 BENIGN PROSTATIC HYPERPLASIA 44
734 CONCOMITANT DISEASE AGGRAVATED 44
735 CONCUSSION 44
736 DEVICE MECHANICAL ISSUE 44
737 DEVICE OCCLUSION 44
738 EOSINOPHILIA 44
739 FOOT AMPUTATION 44
740 FUNGAL SKIN INFECTION 44
741 HEAD DISCOMFORT 44
742 INFUSION SITE HAEMORRHAGE 44
743 MOOD SWINGS 44
744 PERIPHERAL ISCHAEMIA 44
745 POST PROCEDURAL INFECTION 44
746 RESPIRATORY ACIDOSIS 44
747 THERAPY PARTIAL RESPONDER 44
748 UPPER GASTROINTESTINAL HAEMORRHAGE 44
749 ACUTE CORONARY SYNDROME 43
750 BLOOD TEST ABNORMAL 43
751 DEVICE INFUSION ISSUE 43
752 DIASTOLIC DYSFUNCTION 43
753 EAR PAIN 43
754 ENCEPHALOPATHY 43
755 LIVER FUNCTION TEST ABNORMAL 43
756 NERVE COMPRESSION 43
757 PRODUCT PHYSICAL ISSUE 43
758 PROSTATOMEGALY 43
759 RASH PAPULAR 43
760 SECRETION DISCHARGE 43
761 SLUGGISHNESS 43
762 BLOOD THYROID STIMULATING HORMONE INCREASED 42
763 CARDIAC AMYLOIDOSIS 42
764 HYPERVENTILATION 42
765 INJECTION SITE URTICARIA 42
766 ORAL DISCOMFORT 42
767 PRODUCT ODOUR ABNORMAL 42
768 PULMONARY FIBROSIS 42
769 QUALITY OF LIFE DECREASED 42
770 RENAL CANCER 42
771 RENAL CYST 42
772 URINE PROTEIN/CREATININE RATIO INCREASED 42
773 VULVOVAGINAL PAIN 42
774 ACETONAEMIA 41
775 AMPUTATION 41
776 ANGER 41
777 ARTERIOSCLEROSIS CORONARY ARTERY 41
778 EYE HAEMORRHAGE 41
779 GENITAL DISCOMFORT 41
780 HYPERTRIGLYCERIDAEMIA 41
781 IRRITABLE BOWEL SYNDROME 41
782 KNEE OPERATION 41
783 OBSTRUCTIVE SLEEP APNOEA SYNDROME 41
784 PARAESTHESIA ORAL 41
785 PENILE SWELLING 41
786 POLYNEUROPATHY 41
787 RALES 41
788 RESPIRATORY DISTRESS 41
789 BRAIN INJURY 40
790 CARDIAC FLUTTER 40
791 CHOKING 40
792 DEVICE USE ERROR 40
793 FURUNCLE 40
794 GENITAL PAIN 40
795 INCREASED TENDENCY TO BRUISE 40
796 INTERNAL HAEMORRHAGE 40
797 ISCHAEMIC CARDIOMYOPATHY 40
798 JOINT RANGE OF MOTION DECREASED 40
799 MENTAL IMPAIRMENT 40
800 MULTIPLE ALLERGIES 40
801 MULTIPLE SCLEROSIS 40
802 PERINEAL ABSCESS 40
803 POOR VENOUS ACCESS 40
804 PYELONEPHRITIS ACUTE 40
805 RENAL FUNCTION TEST ABNORMAL 40
806 SKIN CANCER 40
807 TOOTH DISORDER 40
808 VASCULITIS 40
809 VITREOUS FLOATERS 40
810 ATRIOVENTRICULAR BLOCK COMPLETE 39
811 BLOOD MAGNESIUM DECREASED 39
812 CORONARY ARTERY STENOSIS 39
813 DEVICE BREAKAGE 39
814 DEVICE FAILURE 39
815 GALLBLADDER DISORDER 39
816 HAEMOGLOBIN ABNORMAL 39
817 HIP ARTHROPLASTY 39
818 HYPOAESTHESIA ORAL 39
819 MATERNAL EXPOSURE DURING PREGNANCY 39
820 PELVIC PAIN 39
821 RESPIRATORY RATE INCREASED 39
822 SCAR 39
823 SCRATCH 39
824 SINUS TACHYCARDIA 39
825 STENT PLACEMENT 39
826 THYROID DISORDER 39
827 VULVOVAGINAL CANDIDIASIS 39
828 ANHEDONIA 38
829 APPETITE DISORDER 38
830 BEDRIDDEN 38
831 EMPHYSEMATOUS PYELONEPHRITIS 38
832 EPILEPSY 38
833 IMMUNE THROMBOCYTOPENIA 38
834 INFUSION SITE PRURITUS 38
835 INSULIN RESISTANCE 38
836 LEFT VENTRICULAR FAILURE 38
837 LEUKOPENIA 38
838 LYMPHOCYTE COUNT DECREASED 38
839 PHARYNGEAL SWELLING 38
840 PRODUCT RESIDUE PRESENT 38
841 SENSITIVITY TO WEATHER CHANGE 38
842 SUICIDE ATTEMPT 38
843 BOWEL MOVEMENT IRREGULARITY 37
844 DERMATITIS ALLERGIC 37
845 DEVICE DEFECTIVE 37
846 DIABETIC KETOSIS 37
847 END STAGE RENAL DISEASE 37
848 EXPOSURE VIA SKIN CONTACT 37
849 GLOMERULAR FILTRATION RATE INCREASED 37
850 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 37
851 INJECTION SITE EXTRAVASATION 37
852 INJECTION SITE NODULE 37
853 LOW DENSITY LIPOPROTEIN INCREASED 37
854 MUCOSAL DRYNESS 37
855 MUSCLE TWITCHING 37
856 MYASTHENIA GRAVIS 37
857 OESOPHAGITIS 37
858 ORTHOPNOEA 37
859 PERINEAL PAIN 37
860 PRODUCT COMMUNICATION ISSUE 37
861 SKIN ABRASION 37
862 URINARY TRACT CANDIDIASIS 37
863 URINE OUTPUT DECREASED 37
864 VAGINAL DISCHARGE 37
865 VASCULAR GRAFT 37
866 DIALYSIS 36
867 DRUG ABUSE 36
868 FACIAL PARALYSIS 36
869 FOOD CRAVING 36
870 GENITAL BURNING SENSATION 36
871 INJECTION SITE DISCOMFORT 36
872 MULTIPLE SCLEROSIS RELAPSE 36
873 NEAR DEATH EXPERIENCE 36
874 NECROSIS 36
875 NERVE INJURY 36
876 OVERWEIGHT 36
877 TOOTH FRACTURE 36
878 TOOTH INFECTION 36
879 WOUND INFECTION 36
880 ACCIDENT 35
881 ANKYLOSING SPONDYLITIS 35
882 ANTINUCLEAR ANTIBODY POSITIVE 35
883 APATHY 35
884 BLOOD CALCIUM INCREASED 35
885 CARDIAC DYSFUNCTION 35
886 COAGULOPATHY 35
887 CORONARY ARTERIAL STENT INSERTION 35
888 DEVICE DISLOCATION 35
889 FEAR 35
890 FOOT DEFORMITY 35
891 FULL BLOOD COUNT DECREASED 35
892 HAEMORRHOIDAL HAEMORRHAGE 35
893 HIATUS HERNIA 35
894 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35
895 LEFT ATRIAL DILATATION 35
896 PARKINSONISM 35
897 PERICARDITIS 35
898 PHYSICAL DECONDITIONING 35
899 PROCTALGIA 35
900 SKIN INFECTION 35
901 TOOTH EXTRACTION 35
902 URINARY TRACT INFECTION BACTERIAL 35
903 BLOOD CHOLESTEROL ABNORMAL 34
904 BODY TEMPERATURE DECREASED 34
905 CLOSTRIDIUM DIFFICILE COLITIS 34
906 DYSLIPIDAEMIA 34
907 GENITAL SWELLING 34
908 HEMIPARESIS 34
909 HYPERLACTACIDAEMIA 34
910 INFARCTION 34
911 INFLAMMATORY MARKER INCREASED 34
912 MUSCULOSKELETAL DISORDER 34
913 PENILE ERYTHEMA 34
914 PERIPHERAL ARTERY OCCLUSION 34
915 PRODUCT DISTRIBUTION ISSUE 34
916 RETINAL DETACHMENT 34
917 SCROTAL ABSCESS 34
918 SUBSTANCE USE 34
919 TYPE 1 DIABETES MELLITUS 34
920 URINARY HESITATION 34
921 VISUAL ACUITY REDUCED 34
922 VITAMIN D DECREASED 34
923 ABNORMAL FAECES 33
924 ANGINA UNSTABLE 33
925 BLOOD BICARBONATE DECREASED 33
926 BRONCHOSPASM 33
927 CHOLECYSTITIS ACUTE 33
928 DENTAL CARIES 33
929 DEVICE USE ISSUE 33
930 DRUG DEPENDENCE 33
931 GASTROINTESTINAL SOUNDS ABNORMAL 33
932 HAEMATOLOGICAL INFECTION 33
933 HAEMODYNAMIC INSTABILITY 33
934 HYPERTENSIVE CRISIS 33
935 HYPERTRANSAMINASAEMIA 33
936 IMMUNODEFICIENCY 33
937 INCORRECT PRODUCT ADMINISTRATION DURATION 33
938 INITIAL INSOMNIA 33
939 LARGE INTESTINE POLYP 33
940 MOUTH ULCERATION 33
941 NEPHRITIS 33
942 OBSTRUCTIVE AIRWAYS DISORDER 33
943 OSTEONECROSIS 33
944 PENIS DISORDER 33
945 PNEUMONIA BACTERIAL 33
946 PSEUDOMONAS INFECTION 33
947 PULSELESS ELECTRICAL ACTIVITY 33
948 SCAB 33
949 SPINAL STENOSIS 33
950 UPPER-AIRWAY COUGH SYNDROME 33
951 UVEITIS 33
952 ACUTE HEPATIC FAILURE 32
953 APPENDICITIS 32
954 ATELECTASIS 32
955 DERMATITIS 32
956 DIABETIC NEPHROPATHY 32
957 DUODENAL ULCER 32
958 ECCHYMOSIS 32
959 GASTROINTESTINAL INFECTION 32
960 GINGIVAL BLEEDING 32
961 HYPERPHAGIA 32
962 HYPOPHOSPHATAEMIA 32
963 IMMUNE-MEDIATED MYOSITIS 32
964 LIGAMENT SPRAIN 32
965 NERVOUS SYSTEM DISORDER 32
966 ODYNOPHAGIA 32
967 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 32
968 PELVIC FRACTURE 32
969 PIGMENTATION DISORDER 32
970 RASH MACULO-PAPULAR 32
971 SPLENOMEGALY 32
972 TENDON RUPTURE 32
973 UMBILICAL HERNIA 32
974 VENTRICULAR HYPOKINESIA 32
975 VULVOVAGINAL SWELLING 32
976 ACUTE RESPIRATORY DISTRESS SYNDROME 31
977 BLOOD CREATININE ABNORMAL 31
978 BODY HEIGHT DECREASED 31
979 CAROTID ARTERIOSCLEROSIS 31
980 CATHETERISATION CARDIAC 31
981 DEMENTIA ALZHEIMER^S TYPE 31
982 FOOD POISONING 31
983 FRUSTRATION TOLERANCE DECREASED 31
984 GASTRIC CANCER 31
985 GLUCOSE TOLERANCE IMPAIRED 31
986 HALLUCINATION, VISUAL 31
987 METASTASES TO BONE 31
988 SENSITIVE SKIN 31
989 STARVATION KETOACIDOSIS 31
990 TESTICULAR PAIN 31
991 WRONG PRODUCT ADMINISTERED 31
992 ANOSMIA 30
993 AORTIC ARTERIOSCLEROSIS 30
994 CRYING 30
995 CYTOKINE RELEASE SYNDROME 30
996 DEVICE RELATED INFECTION 30
997 FACIAL PAIN 30
998 GLYCOSYLATED HAEMOGLOBIN 30
999 GYNAECOMASTIA 30